Molecular Cytogenetics (Sep 2020)

Sole trisomy 6 an uncommon finding in pediatric acute myeloid leukemia, probably associated to bad prognosis

  • Sinhue Alejandro Brukman-Jimenez,
  • Lucina Bobadilla-Morales,
  • Jorge Román Corona-Rivera,
  • Pablo Alejandro Chávez-Panduro,
  • Citlalli Ortega-de-la-Torre,
  • Uriel Francisco Santana-Bejarano,
  • Elizabeth Torres-Anguiano,
  • Lucero Mendoza-Maldonado,
  • Fernando Antonio Sánchez-Zubieta,
  • Alfredo Corona-Rivera

DOI
https://doi.org/10.1186/s13039-020-00509-y
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Background Acute leukemias represent the main malignancies occurring among children under the age of 15 years. Around 17% corresponds to acute myeloid leukemia (AML). The cytogenetic analysis of bone marrow complements the diagnosis of hematological malignancies, therefore finding chromosomal aberrations provides a more reliable prognosis of the disease. Among the cytogenetic aberrations, sole trisomy is frequent in malignant neoplasias, but few cases related to AML have been reported. Case presentation We report a sole trisomy 6 in a pediatric patient diagnosed as AML M4 and poor progression. We carried out a literature review of AML patients with sole trisomy 6 and compared their evolution against AML patients with normal karyotype. Conclusions This is the first case of pediatric AML M4 with this cytogenetic finding. Sole trisomy 6 is infrequently reported in AML but scarce in pediatric cases. Based on overall survival analysis, we suggest that sole trisomy 6 could be associated with poor prognosis, in both, adult as well as pediatric AML.

Keywords